Deucravacitinib: is there still a place or a need for a new oral agent?

Journal Article Deucravacitinib: is there still a place or a need for a new oral agent? Get access Francesca Sampogna, Francesca Sampogna Conceptualization, Writing - original draft, Writing - review & editing Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome Correspondence: Francesca Sampogna. Email: fg.sampogna@gmail.com Search for other works by this author on: Oxford Academic Google Scholar Stefano Piaserico Stefano Piaserico Conceptualization, Writing - original draft, Writing - review & editing Dermatology Unit, Department of Medicine, University of Padua, Italy Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 190, Issue 5, May 2024, Pages 610–611, https://doi.org/10.1093/bjd/ljae087 Published: 26 February 2024 Article history Accepted: 18 January 2024 Received: 15 February 2024 Revision received: 20 February 2024 Published: 26 February 2024 Corrected and typeset: 21 March 2024